57 related articles for article (PubMed ID: 33125112)
1. Molecular alterations and clinical relevance in cervical carcinoma and precursors (Review).
Sheng J; Xiang Y; Shang L; He Q
Oncol Rep; 2020 Dec; 44(6):2397-2405. PubMed ID: 33125112
[TBL] [Abstract][Full Text] [Related]
2. ASC-US diagnosis and triage.
Del Mistro A
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S2-4. PubMed ID: 17727939
[No Abstract] [Full Text] [Related]
3. [Microsatellite instability and human papilloma virus genotypes in preneoplastic and neoplastic uterine cervix lesions].
Roa S JC; Martínez S R; Montenegro S; Roa E I; Capurro V I; Ibacache S G; Melo A A
Rev Med Chil; 2007 Jan; 135(1):37-44. PubMed ID: 17369982
[TBL] [Abstract][Full Text] [Related]
4. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
[TBL] [Abstract][Full Text] [Related]
5. A metabolite profiling method for diagnosis of precancerous cervical lesions and HPV persistence.
Walker H; Burrell M; Flatley J; Powers H
Bioanalysis; 2017 Apr; 9(8):601-608. PubMed ID: 28508693
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation and detection of cervical cancer and precancerous lesions using molecular methods.
Mersakova S; Nachajova M; Szepe P; Kasajova PS; Halasova E
Tumour Biol; 2016 Jan; 37(1):23-7. PubMed ID: 26459314
[TBL] [Abstract][Full Text] [Related]
7. Methylation of p16 ink4a promoter is independent of human papillomavirus DNA physical state: a comparison between cervical pre-neoplastic and neoplastic samples.
Carestiato FN; Amaro-Filho SM; Moreira MAM; Cavalcanti SMB
Mem Inst Oswaldo Cruz; 2018 Dec; 114():e180456. PubMed ID: 30569945
[TBL] [Abstract][Full Text] [Related]
8. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.
Vinokurova S; Wentzensen N; Kraus I; Klaes R; Driesch C; Melsheimer P; Kisseljov F; Dürst M; Schneider A; von Knebel Doeberitz M
Cancer Res; 2008 Jan; 68(1):307-13. PubMed ID: 18172324
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia.
Cuschieri K; Wentzensen N
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2536-45. PubMed ID: 18842994
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
[TBL] [Abstract][Full Text] [Related]
11. [Comparision of cytological study results and data of bio-molecular assay hybrid capture II in patients with precancer of the cervix uteri].
Podistov IuI
Klin Lab Diagn; 2005 Aug; (8):43-5. PubMed ID: 16218339
[No Abstract] [Full Text] [Related]
12. Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
Schiffman M; Kinney WK; Cheung LC; Gage JC; Fetterman B; Poitras NE; Lorey TS; Wentzensen N; Befano B; Schussler J; Katki HA; Castle PE
J Natl Cancer Inst; 2018 May; 110(5):501-508. PubMed ID: 29145648
[TBL] [Abstract][Full Text] [Related]
13. hTERT Protein Expression in Cytoplasm and Nucleus and its Association With HPV Infection in Patients With Cervical Cancer.
Moreno-Acosta P; Molano M; Morales N; Acosta J; GonzÁlez-Prieto C; Mayorga D; Buitrago L; Gamboa O; MejÍa JC; Castro J; Romero-Rojas A; Espenel S; Murray GL; Garland SM; Vallard A; MagnÉ N
Cancer Genomics Proteomics; 2020; 17(5):615-625. PubMed ID: 32859640
[TBL] [Abstract][Full Text] [Related]
14. [Global expression analysis in uterine cervical cancer: metabolic pathways and altered genes].
Vázquez-Ortíz G; Piña-Sanchez P; Hidalgo A; Lazos M; Moreno J; Alvarado I; Cruz F; Hernández DM; Pérez-Plascencia C; Salcedo M
Rev Invest Clin; 2005; 57(3):434-41. PubMed ID: 16187704
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation of CDH13, DAPK1 and TWIST1 genes in precancerous and cancerous lesions of the uterine cervix.
Missaoui N; Hmissa S; Trabelsi A; Traoré C; Mokni M; Dante R; Frappart L
Pathol Res Pract; 2011 Jan; 207(1):37-42. PubMed ID: 21129853
[TBL] [Abstract][Full Text] [Related]
16. The synergic effect of HPV infection and epigenetic anomaly of the p16 gene in the development of cervical cancer.
Ahmad A; Raish M; Shahid M; Batra S; Batra V; Husain SA
Cancer Biomark; 2017 Jul; 19(4):375-381. PubMed ID: 28453456
[TBL] [Abstract][Full Text] [Related]
17. 3'UTR polymorphism of Thymidylate Synthase gene increased the risk of persistence of pre-neoplastic cervical lesions.
Silva NNT; Santos ACS; Nogueira VM; Carneiro CM; Lima AA
BMC Cancer; 2020 Apr; 20(1):323. PubMed ID: 32295543
[TBL] [Abstract][Full Text] [Related]
18. Elevated levels of tetraploid cervical cells in human papillomavirus-positive Papanicolaou smears diagnosed as atypical squamous cells of undetermined significance.
Olaharski AJ; Eastmond DA
Cancer; 2004 Jun; 102(3):192-9. PubMed ID: 15211479
[TBL] [Abstract][Full Text] [Related]
19. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
Cox JT;
Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
[TBL] [Abstract][Full Text] [Related]
20. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
